Inventor · disambiguated record
Farzaneh Seyedi
Also filed as: SEYEDI FARZANEH
7 granted patents·8 pending applications·15 citations·filing 2008–2024
79Inventor score
Files withPARATEK PHARM INNC4ACETYLON PHARMACEUTICALS INC2ALLERGAN PHARMACEUTICALS INT LTD2VERASTEM INC2BERNIAC JOEL1
Top patents by PatentIndex Score
15 records- 0189US11873296B2Solid forms of a dual RAF/MEK inhibitorVERASTEM INC·Filed 2022·Granted Jan 16, 2024·2 cites·27 claims
- 0285US2025340507A1Methods for synthesizing substituted tetracycline compoundsPARATEK PHARM INNC·Filed 2024·Application pending·0 cites
- 0383US10144714B2Methods of making protein deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Dec 4, 2018·3 cites·15 claims
- 0483US9522872B2Methods for synthesizing substituted tetracycline compoundsSEYEDI FARZANEH·Filed 2008·Granted Dec 20, 2016·7 cites·14 claims
- 0572US12509450B2Solid forms of a dual RAF/MEK inhibitorVERASTEM INC·Filed 2023·Granted Dec 30, 2025·0 cites·20 claims
- 0668US10464906B2Crystalline forms of a histone deacetylase inhibitorACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Nov 5, 2019·1 cites·4 claims
- 0767US9255068B2Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the sameCOULTER CATHERINE·Filed 2012·Granted Feb 9, 2016·2 cites·72 claims
- 0861US2017283368A1Methods for synthesizing substituted tetracycline compoundsPARATEK PHARM INNC·Filed 2016·Application pending·0 cites
- 0958US2020024223A1Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the sameALLERGAN PHARMACEUTICALS INT LTD·Filed 2019·Application pending·0 cites
- 1056US2024100011A1Pediatric formulations of ferric citrateKERYX BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1155US2019040002A1Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the sameALLERGAN PHARMACEUTICALS INT LTD·Filed 2018·Application pending·0 cites
- 1253US2016039749A111a, 12-DERIVATIVES OF TETRACYCLINE COMPOUNDSBERNIAC JOEL·Filed 2013·Application pending·0 cites
- 1348US2016200671A1Crystalline salts of (4s, 4as, 5ar, 12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the sameWARNER CHILCOTT CO LLC·Filed 2015·Application pending·0 cites
- 1442US12297161B2Process for making sarecycline hydrochloridePARATEK PHARM INNC·Filed 2019·Granted May 13, 2025·0 cites·10 claims
- 1540US2013302442A1Methods of using (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amidePARATEK PHARM INNC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Farzaneh Seyedi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →